ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,836Medicare Part D Prescriptions Filled, Including Refills

Rank: 358 out of 5254

$1.3M Total Retail Price of All Prescriptions

Rank: 175 out of 5254

351 Patients Receiving at Least One Drug in Part D
92% Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New York
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

48% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%. This is far more than peers.

Prescription Price

$94 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New York
NEXIUM 420 415* 65 1 18
AMLODIPINE BESYLATE 363 350 50 2 2
CRESTOR 347 333 56 3 16
CLOPIDOGREL 321 304 45 4 15
SYNTHROID 304 289 35 5 30
LOSARTAN POTASSIUM 282 264 37 6 12
METOPROLOL SUCCINATE 265 230 35 7 10
SIMVASTATIN 253 236 43 8 1
CREON 227 222* 39 9 107
LOVAZA 204 169 30 10 43
CARVEDILOL 200 189 30 11 25
COUMADIN 199 199 20 12 128
METOPROLOL TARTRATE 192 187* 30 13 9
BENICAR 190 190 25 14 94
ISOSORBIDE MONONITRATE ER 187 182* 23 15 47
ESCITALOPRAM OXALATE 187 182* 31 15 59
HYDRALAZINE HCL 181 176* 23 17 68
ZOLPIDEM TARTRATE 180 180 33 18 17
HYDROCHLOROTHIAZIDE 179 174* 32 19 11
ATORVASTATIN CALCIUM 177 154 25 20 3
OMEPRAZOLE 174 148 38 21 5
ATENOLOL 155 150* 18 22 14
ADVAIR DISKUS 149 144* 33 23 32
PRANDIN 139 134* 21 24 203
DIOVAN 129 129 25 25 23
TAMSULOSIN HCL 126 126 16 26 19
ALENDRONATE SODIUM 124 124 16 27 22
PRAVASTATIN SODIUM 123 111 18 28 21
ZETIA 122 122 16 29 70
FUROSEMIDE 119 119 27 30 8
LOSARTAN-HYDROCHLOROTHIAZIDE 115 110* 17 31 29
METFORMIN HCL 115 110* 20 31 7
JANUVIA 109 104* 17 33 26
LEVOTHYROXINE SODIUM 107 107 12 34 4
MONTELUKAST SODIUM 106 83 26 35 35
ATELVIA 105 105 11 36 163
DOXAZOSIN MESYLATE 100 100 14 37 101
DEXILANT 100 100 20 37 102
MICARDIS 98 76 12 39 187
RANITIDINE HCL 97 92* 15 40 41
AMITIZA 95 95 14 41 159
BENICAR HCT 92 87* 15 42 100
MECLIZINE HCL 91 91 24 43 79
ENALAPRIL MALEATE 90 85* 19 44 24
GLYBURIDE-METFORMIN HCL 84 <11 <11 R 45 104
GLIPIZIDE ER 84 73 12 45 121
VICTOZA 3-PAK 83 78* 12 47 294
NAMENDA 82 82 14 48 38
VOLTAREN 80 75* 27 49 65
MELOXICAM 77 72* 29 50 51
JANUMET 76 <11 <11 51 74
ALLOPURINOL 73 <11 <11 52 40
FAMOTIDINE* 73 62 18 52 56
TRADJENTA 72 67* 11 54 223
ALCOHOL PREP PADS 72 67* 14 54 140
DONEPEZIL HCL 71 71 12 56 28
DILTIAZEM 24HR CD 71 <11 <11 56 133
CELEBREX 71 66* 21 56 76
GABAPENTIN 70 <11 <11 59 20
VALSARTAN-HYDROCHLOROTHIAZIDE 70 70 11 59 49
AMLODIPINE BESYLATE-BENAZEPRIL 69 <11 <11 61 60
ALCOHOL SWABS 67 62* 15 62 146
TOPROL XL 66 <11 <11 63 208
GLIMEPIRIDE 66 61* 13 63 37
AVODART 64 <11 <11 65 115
LIDODERM 63 58* 21 66 64
LISINOPRIL 63 58* 14 66 6
GLYBURIDE 63 <11 <11 R 66 96
LORAZEPAM 61 56* 22 B 69 85
NITROGLYCERIN PATCH 61 61 11 69 170
SERTRALINE HCL 58 <11 <11 71 27
WARFARIN SODIUM 58 <11 <11 71 13
ACTONEL 57 <11 <11 73 189
CLONIDINE HCL 54 54 13 74 84
METFORMIN HCL ER 54 <11 <11 74 53
SPIRIVA 53 <11 <11 76 55
KOMBIGLYZE XR 53 <11 <11 76 300
WELCHOL 52 <11 <11 78 200
CITALOPRAM HBR 51 51 11 79 36
TRAMADOL HCL-ACETAMINOPHEN 51 46* 25 79 172
NASONEX 51 46* 23 79 144
NIFEDIPINE ER 50 <11 <11 82 48
LANTUS SOLOSTAR 50 <11 <11 82 61
RANEXA 50 <11 <11 82 157
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.